Drug class
Imidazole antifungal agent
Mechanism of action
Inhibits fungal ergosterol biosynthesis, principally through inhibition of lanosterol 14α-demethylase and additional effects on sterol pathways, disrupting fungal cell-membrane structure and function.
General use cases
- Topical treatment of superficial dermatophyte and yeast infections of the skin, including tinea pedis and other cutaneous mycoses, according to the locally authorised formulation
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
